.
RELAXO financial statements
* Numbers in millions
| Capitalization * | 288 681 |
|---|---|
| EV * | 218 653 |
| Number of shares * | 248 |
| EPS | 11,74 |
| Revenue * | 23 456 |
| Net income * | 2 916 |
| Operating profit * | 3 901 |
| Total liabilities * | 6 034 |
| Net debt * | 1 378 |
| Total assets * | 21 758 |
| Equity * | 15 724 |
| Cash and investments * | 3 443 |
.
RELAXO valuation
| P/E | 99,01 |
|---|---|
| P/B | 18,36 |
| P/S | 12,31 |
| E/P | 1 |
| P/FCF | 74,06 |
.
RELAXO profitability
| ROE | 19% |
|---|---|
| ROA% | 14% |
| ROIC% | 23% |